Catalyst Wire Dossier Catalyst Wire Dossier

Soliqua (insulin glargine/lixisenatide)

insulin glargine/lixisenatide · Sanofi
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Soliqua (insulin glargine/lixisenatide), covering 2017-02-10 to 2017-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients [Phase 2]

See pricing